Will the entire current Cardio-Renal team make it to Vegas?

Quote

anonymous

Guest
Does it make sense with Entresto LOE imminent to send the entire Cardio-Renal to Vegas? Let’s be serious, they could easily make 2 rep territories 1 in an instant with no effect on coverage.
 












Yeah, they’ll be in Vegas because big pharma does nonsensical things like spending millions on a Vegas meeting only to layoff hundreds of the very people who just attended that very meeting. Layoffs are coming, either stay and await your fate or leave now.
 








I worked for a company as our product went off patent. We continued to promote for over a year until a new product came out for us. They won’t want to give up their Entresto sales overnight and the generic company won’t have reps going into offices. Many prescribers won’t catch on that there is a generic unless you tell them (I won’t).
 




anonymous said:
I worked for a company as our product went off patent. We continued to promote for over a year until a new product came out for us. They won’t want to give up their Entresto sales overnight and the generic company won’t have reps going into offices. Many prescribers won’t catch on that there is a generic unless you tell them (I won’t).
Click to expand...

What color is the sky in your world?
What year did this happen? 1995?
Virtually every cardiology office will know 72 hours after approval. Its not like Teva and the other biosim companies don't know how to reach the prescribers.
Oh, and patients will come in asking for it, especially when their pharmacy forces a therapeutic interchange on them.
Grow up.
 




anonymous said:
I worked for a company as our product went off patent. We continued to promote for over a year until a new product came out for us. They won’t want to give up their Entresto sales overnight and the generic company won’t have reps going into offices. Many prescribers won’t catch on that there is a generic unless you tell them (I won’t).
Click to expand...
Dumbest comment ever
 




anonymous said:
What color is the sky in your world?
What year did this happen? 1995?
Virtually every cardiology office will know 72 hours after approval. Its not like Teva and the other biosim companies don't know how to reach the prescribers.
Oh, and patients will come in asking for it, especially when their pharmacy forces a therapeutic interchange on them.
Grow up.
Click to expand...
Have you ever had your product go generic? What happened?
 




anonymous said:
Have you ever had your product go generic? What happened?
Click to expand...

I have. The news travels fast these days, especially with the extreme pressures placed on insurance companies AND the pharmacies they have a very vested interest in. As a previous poster said, it’s not 1995 anymore. Also, our federal government is much more active in preventing pharma companies from playing the delay game. Novartis makes more money by laying off salespeople and the slow transfer from branded Entresto to generic takes place.
 








anonymous said:
Anyone in this industry for more than a decade has been through it. Ask anybody on your team. There's no way to sugarcoat it, so I expect you'll hear it straight. Picture worst-case scenarios and you're getting warm.
Click to expand...
Well, I’ve been through it and the company had us keep promoting the branded product for over a year after generic hit the market to preserve as much business as possible. And it wasn’t “1995.”
 




anonymous said:
Well, I’ve been through it and the company had us keep promoting the branded product for over a year after generic hit the market to preserve as much business as possible. And it wasn’t “1995.”
Click to expand...

Your comment has nothing to do with how many people they need.
You can't possibly believe they'll keep the sales force as it's currently constructed to sell a medication with a biosimiliar competetor, can you?
I have been through it a few times, and it has never worked that way. They cut by 40 or 50%, just like they will this time.
Why wouldn't they? I don't really understand what they're waiting for.
One person can easily promote Leqvio and drop the last couple of samples of Entresto.
Business preservation isn't up to Novartis, it's up to the insurers. They'll be aware as soon as there is approval, if not sooner, and adjust their coverages accordingly.
 




Agree. I have been through before with Novartis. Was a while ago. When Diovan went generic, it did take the generic company 6 or so months before the generic was avail in the pharmacy’s. Also, when did become available it was expense until a 2nd generic company entered the market. Once it was announced generic coming out, there was a layoff. People that remained still promoted Diovan and samples were not given.

Then maybe a year later, Diovan promotion stopped. Another layoff. Remaining reps promoted Exelon Patch. That lasted 2 years ish? Then another layoff. 3 months after that layoff one random day we were told Exelon Patch done and reps would be trained on heart failure. We went out and talked about heart failure until Entrestro launched. Then Novartis went crazy and mass hired reps for Entresto after laying off 8 months earlier. Entresto did launch earlier than expected however. Even if Pelacarsen launches around same time Entrestro goes, hard to see needing this many people. We don’t need this many now.
 




anonymous said:
I worked for a company as our product went off patent. We continued to promote for over a year until a new product came out for us. They won’t want to give up their Entresto sales overnight and the generic company won’t have reps going into offices. Many prescribers won’t catch on that there is a generic unless you tell them (I won’t).
Click to expand...

Once Entresto goes generic, the refill and new Entresto prescriptions will be switched at the pharmacy and PBM to the generic Entresto automatically. The prescribers don't control the narrative.
 




anonymous said:
Your comment has nothing to do with how many people they need.
You can't possibly believe they'll keep the sales force as it's currently constructed to sell a medication with a biosimiliar competetor, can you?
I have been through it a few times, and it has never worked that way. They cut by 40 or 50%, just like they will this time.
Why wouldn't they? I don't really understand what they're waiting for.
One person can easily promote Leqvio and drop the last couple of samples of Entresto.
Business preservation isn't up to Novartis, it's up to the insurers. They'll be aware as soon as there is approval, if not sooner, and adjust their coverages accordingly.
Click to expand...
LOL!!! Where have you been?? Entresto does not sell itself and it’s the biggest money maker for the company. NVS certainly just isn’t going to drop the cash cow. These posts are hilarious.
 
















it really doesn’t matter, assume it’s going to happen next month. What should you be doing to get yourself ready? Do it. That’s what the highest performing people will do and you’ll see some good people leave on their own over the next several months. In the end, no one is really safe, you’ve got to do what is in your own best interest.
 




Top Bottom
Back
Quote